PLPP2
Basic information
Region (hg38): 19:281040-291403
Previous symbols: [ "PPAP2C" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (47 variants)
- PLPP2-related_disorder (2 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLPP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003712.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 42 | 45 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 0 | 0 | 46 | 4 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PLPP2 | protein_coding | protein_coding | ENST00000327790 | 6 | 10354 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000831 | 0.939 | 125702 | 0 | 41 | 125743 | 0.000163 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.492 | 151 | 169 | 0.894 | 0.0000109 | 1931 |
| Missense in Polyphen | 51 | 63.417 | 0.8042 | 728 | ||
| Synonymous | 0.409 | 73 | 77.6 | 0.941 | 0.00000543 | 666 |
| Loss of Function | 1.66 | 7 | 13.6 | 0.514 | 8.51e-7 | 139 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000580 | 0.0000580 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000544 | 0.000544 |
| Finnish | 0.0000464 | 0.0000462 |
| European (Non-Finnish) | 0.000213 | 0.000211 |
| Middle Eastern | 0.000544 | 0.000544 |
| South Asian | 0.0000982 | 0.0000980 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of phosphatidic acid (PA) to diacylglycerol (DG). In addition it hydrolyzes lysophosphatidic acid (LPA), ceramide-1-phosphate (C-1-P) and sphingosine-1- phosphate (S-1-P). The relative catalytic efficiency is PA > C-1-P > LPA > S-1-P.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);Glycerolipid metabolism - Homo sapiens (human);Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Fat digestion and absorption - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);Familial lipoprotein lipase deficiency;Glycerolipid Metabolism;Glycerol Kinase Deficiency;D-glyceric acidura;Triacylglyceride Synthesis;Metabolism of lipids;Metabolism;triacylglycerol biosynthesis;Sphingolipid de novo biosynthesis;Sphingolipid metabolism
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.69
Haploinsufficiency Scores
- pHI
- 0.454
- hipred
- N
- hipred_score
- 0.454
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Plpp2
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- protein dephosphorylation;phospholipid metabolic process;sphingolipid biosynthetic process;phospholipid dephosphorylation
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- phosphoprotein phosphatase activity;protein binding;phosphatidate phosphatase activity;phosphatase activity;sphingosine-1-phosphate phosphatase activity;lipid phosphatase activity